Curanex Pharmaceuticals (CURX) Assets Average (2025)

Curanex Pharmaceuticals' (CURX) quarterly Assets Average came in at $13.0 million in Q4 2025, up 70.7% on a QoQ basis from $7.6 million in Q3 2025.

Curanex Pharmaceuticals (CURX) Assets Average (2025) Analysis & Trends

Curanex Pharmaceuticals (CURX) has 1 years of Assets Average data on file, last reported at $13.0 million in Q4 2025.

Quarterly Assets Average changed N/A year-over-year to $13.0 million in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $13.0 million (changed N/A YoY) and the FY2025 annual result came in at $6.0 million, changed N/A from the prior year.
Assets Average climbed to $13.0 million in Q4 2025, from $7.6 million in the prior quarter.
In the past five years, Assets Average ranged from a high of $13.0 million in Q4 2025 to a low of $652554.5 in Q2 2025.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)	Assets Avg. (Qtr)
1	Vertex Pharmaceuticals	137.11 Bn	129.26 Bn	2.84 Bn	26.95 Bn
2	Regeneron Pharmaceuticals	84.98 Bn	76.99 Bn	3.93 Bn	41.30 Bn
3	Argenx Se	64.52 Bn	59.33 Bn	1.37 Bn	-
4	Moderna	53.23 Bn	48.09 Bn	52.00 Mn	11.22 Bn
5	BeOne Medicines	41.23 Bn	36.14 Bn	1.53 Bn	8.86 Bn
6	Alnylam Pharmaceuticals	30.65 Bn	27.34 Bn	992.69 Mn	5.34 Bn
7	Insmed	27.15 Bn	25.99 Bn	358.27 Mn	2.09 Bn
8	Royalty Pharma	26.98 Bn	26.14 Bn	-	19.82 Bn
9	BioNTech SE	26.78 Bn	8.39 Bn	668.28 Mn	25.27 Bn
10	Curanex Pharmaceuticals	6.11 Mn	1.11 Mn	-	13.03 Mn

Download Data